Late-onset <i>NPM1</i> mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib
oleh: Sonia Jaramillo, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard F. Schlenk, Michael Hundemer, Lars Velten, Caroline Pabst
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2024-05-01 |
Deskripsi
Not available.